Solventum Corp
Research Solventum Corp (SOLV) on Bullrun: valuation model: 126.7% undervalued, market cap USD 13.55B, P/E 9.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSOLV
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal126.7% undervalued
- Market capUSD 13.55B
- P/E9.6
- Financial periodFY2025
- RevenueUSD 8.33B
- Revenue growth0.9%
- Net incomeUSD 1.56B
- Free cash flow-USD 10.00M
- Gross margin53.5%
Valuation Snapshot
Bullrun's latest valuation model marks Solventum Corp as 126.7% undervalued; latest market cap is USD 13.55B; P/E is 9.6.
About Solventum Corp
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.
Frequently asked questions
Is Solventum Corp overvalued or undervalued?
Bullrun's valuation model currently marks Solventum Corp as 126.7% undervalued.
What is Solventum Corp's market cap?
Solventum Corp's market capitalization is USD 13.55B.
What is Solventum Corp's P/E ratio?
Solventum Corp's price-to-earnings (P/E) ratio is 9.6.
What does Solventum Corp do?
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.